Back to search
Acute Hepatic Porphyria
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Hepatic Porphyria trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Hepatic Porphyria trials you may qualify forThis global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further char…
The main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria). Aim: Investig…
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pr…
This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porp…
The purpose of this study is to determine if Panhematin is safe and effective for prevention of acute attacks of porphyria. The study aims to provide high qual…
To determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent f…
Postural Tachycardia Syndrome (POTS) is the most common autonomic disorder and is estimated to affect 3,000,000 individuals in the United States, with 80-85% of…